Julen Oyarzabal

14PUBLICATIONS
40CO-AUTHORS
Molecular medicineMolecular targetsBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 03, 2022
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage.

Manuel Navarro-Oviedo, Juan Marta-Enguita, Carmen Roncal

|Mar 04, 2021
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.

Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre

|Dec 23, 2020
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.

Vicente Fresquet, Maria J Garcia-Barchino, Marta Larrayoz

|Aug 14, 2020
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis.

Sandra Codony, Eugènia Pujol, Javier Pizarro

|Feb 16, 2020
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.

Edgar López-López, Obdulia Rabal, Julen Oyarzabal

|Aug 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.

Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor

Pageof 3

Frequent Collaborators

7 joint publications

Obdulia Rabal

2 joint publications

Marta Larrayoz

1 joint publications

Martin Krallinger

1 joint publications

Anália Lourenço